OEP News
Media Reports 14 Sep. 2021
Oep competes for a share of the aesthetic medicine market with more than ten billion
MORE
Media Reports 14 Sep. 2021
OEP invests NT$168 million in Caliway to explore the aesthetic medicine market
MORE
Press Release 01 Sep. 2021
OEP invests NT$168M to Caliway to obtain exclusive distributing right of CBL-514 in Taiwan
MORE
Explore OEP
About OEP
Built on understanding and meeting the real needs of people,
OEP is aim to become a benchmark enterprise in the Asia Pacific
Careers
Sincerely invite you to join OEP
Business Development
Continues to introduce a diverse range of innovative products and
expanding its overseas markets
Investors
Monthly Revenues 2021 September
CSR
OEP hopes to create a better society through continuous efforts and innovation
OEP Subsidiaries
Orient PHARMA, OP NanoPharma &
OEP Innovations
Overseas Business
To follow the trend of internationalization, Orient EuroPharma started to expand the foreign market in 1993 by establishing subsidiaries in Southeast Asia and moved into the Mainland China market with a complete marketing network.
